Related Experiment Videos
Intrathecal baclofen for severe spasticity: five years experience.
E G Stewart-Wynne1, P L Silbert, S Buffery
1Department of Neurology, Royal Perth Hospital.
Clinical and Experimental Neurology
|January 1, 1991
Summary
Intrathecal baclofen offers a safe and effective solution for severe spasticity when oral baclofen is insufficient. This therapy complements physical therapy for improved patient outcomes in spinal cord and cerebral hemisphere dysfunction.
Area of Science:
- Neurology
- Rehabilitation Medicine
- Pharmacology
Background:
- Severe spasticity significantly impedes rehabilitation following spinal cord or cerebral hemisphere injuries.
- Oral baclofen is a common treatment, but often inadequate for severe cases.
- Intrathecal baclofen delivery presents an alternative for managing refractory spasticity.
Purpose of the Study:
- To present a comprehensive program for utilizing intrathecal baclofen in severe spasticity management.
- To detail patient assessment, drug administration, and complication management for this therapy.
- To evaluate the benefits of continuous intrathecal baclofen as an adjunct to physical therapy.
Main Methods:
- Development of a 5-year program for intrathecal baclofen therapy.
- Systematic patient assessment protocols.
- Guidelines for practical drug administration and complication monitoring.
Main Results:
- Continuous intrathecal baclofen was found to be safe and effective.
- The therapy serves as a valuable adjunct to physical therapy.
- Improved spasticity control was observed in patients with severe conditions.
Conclusions:
- Intrathecal baclofen is a viable and effective treatment for severe spasticity.
- This approach enhances the management of patients with neurological dysfunction.
- The program facilitates safe and beneficial application of intrathecal baclofen therapy.